(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ Composite: INO) dropped 5.36% to $7.95 at 16:17 EST on Friday, following the last session’s downward trend. NASDAQ Composite is sliding 0.87% to $15,115.49, after two consecutive sessions in a row of losses. This seems, up to now, a somewhat bearish trend trading session today.
Inovio Pharmaceuticals’s last close was $8.52, 55.16% below its 52-week high of $19.00.
Today’s last reported volume for Inovio Pharmaceuticals is 5539247 which is 18.36% above its average volume of 4679962.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 2.2% for the current quarter and 311% for the next. The company’s growth estimates for the ongoing quarter is 69.9% and a drop 400% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 72%, now sitting on 6.46M for the twelve trailing months.
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $7.95 at 16:17 EST, way under its 52-week high of $19.00 and way above its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s worth is below its 50-day moving average of $8.60 and under its 200-day moving average of $8.63.
More news about Inovio Pharmaceuticals (INO).